Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Asset Writedowns and Impairment (2016 - 2025)

SRx Health Solutions' Asset Writedowns and Impairment history spans 5 years, with the latest figure at $2.7 million for Q2 2025.

  • For Q2 2025, Asset Writedowns and Impairment fell 68.47% year-over-year to $2.7 million; the TTM value through Jun 2025 reached $12.9 million, down 26.44%, while the annual FY2023 figure was $8.5 million, 371.64% up from the prior year.
  • Asset Writedowns and Impairment reached $2.7 million in Q2 2025 per SRXH's latest filing, up from $43000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $9.5 million in Q4 2023 to a low of -$682000.0 in Q1 2023.
  • Average Asset Writedowns and Impairment over 4 years is $1.8 million, with a median of $222000.0 recorded in 2022.
  • Peak YoY movement for Asset Writedowns and Impairment: plummeted 407.21% in 2023, then surged 6220.0% in 2024.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at $1.3 million in 2022, then soared by 633.36% to $9.5 million in 2023, then tumbled by 83.19% to $1.6 million in 2024, then skyrocketed by 68.12% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Asset Writedowns and Impairment are $2.7 million (Q2 2025), $43000.0 (Q1 2025), and $1.6 million (Q3 2024).